Medical Bulletin 1/October/2022 Isra Zaman1 Oct 2022 2:38 PM ISTHere are the top medical news for the day:Another possible monkey virus spillover threat for humansAn obscure family of viruses, already endemic in...
New marker of ALS outcome identified Isra Zaman1 Oct 2022 10:00 AM ISTA study by Human Brain Project (HBP) researchers has identified a new marker for predicting the clinical outcome of patients with Amyotrophic Lateral...
Stem cell-gene therapy for ALS: Recent trial Isra Zaman6 Sept 2022 9:15 AM ISTCedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the...
Ultrahigh-dose methylcobalamin was efficacious in Amyotrophic Lateral Sclerosis: JAMA Dr. Shravani Dali19 Jun 2022 8:00 PM ISTUltrahigh-dose methylcobalamin was efficacious in slowing functional decline in patients with early-stage ALS and with moderate progression rate...
Amylyx Pharma bags first approval for Amyotrophic lateral sclerosis drug Albrioza from Canada Ruchika Sharma14 Jun 2022 11:00 AM ISTALS is a relentlessly progressive and fatal neurodegenerative disorder caused by motor neuron death in the brain and spinal cord.
Eisai gets Japanese orphan drug designation for ultrahigh-dose mecobalamin with prospective indication for functional impairment of amyotrophic lateral sclerosis Ruchika Sharma30 May 2022 11:00 AM ISTALS is an intractable, progressive, neurodegenerative disease that results in severe muscle atrophy and weakness in the muscles due to motor neuron...
High-dose methylcobalamin slows functional decline in early-stage amyotrophic lateral sclerosis: JAMA Dr. Hiral patel23 May 2022 7:00 PM ISTJAPAN: Ultra-high-dose of methylcobalamin in patients with early-stage amyotrophic lateral sclerosis (ALS) and with a moderate progression rate is...
Brain computer interface technology empowers Fully Paralyzed Patient to Communicate Dr. Nandita Mohan29 March 2022 4:45 PM ISTAmyotrophic lateral sclerosis (ALS) or often called Lou Gehrig's disease, after the baseball player who was diagnosed with it is a progressive nervous...
Brain-computer interface technology empowers Fully Paralyzed Patient to Communicate MD Editorial Team28 March 2022 5:15 AM ISTAmyotrophic lateral sclerosis (ALS) or often called Lou Gehrig's disease, after the baseball player who was diagnosed with it is a progressive nervous...
Lifetime of heavy physical activity on the job doubles risk of developing ALS: Study Hina Zahid23 Oct 2021 9:00 AM ISTMINNEAPOLIS - There is debate over whether vigorous physical activity is a risk factor for amyotrophic lateral sclerosis (ALS).Lifetime of heavy...
Despite ALS drug trial failing main goal, Biogen says data are encouraging Ruchika Sharma18 Oct 2021 1:02 PM ISTNew Delhi: A late-stage trial of Biogen Inc's experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its...
New Imaging technique effectively measures mitochondrial dysfunction in motor neuron disease Hina Zahid17 Jan 2021 1:00 PM ISTResearchers from the Sheffield Institute for Translational Neuroscience (SITraN) have used a new imaging technique to measure the function of...
